Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])

Publication | Closed Access

Left Ventricular Mass and Volume With Telmisartan, Ramipril, or Combination in Patients With Previous Atherosclerotic Events or With Diabetes Mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])

DOI

Citations

References

2009

Year

Brett R. Cowan, Alistair A. Young, Craig S. Anderson, Robert N. Doughty, Rungroj Krittayaphong, Eva Lonn, Thomas H. Marwick, Chris Reid, John E. Sanderson, Roland E. Schmieder,

The American Journal of Cardiology

Ongoing Telmisartan AloneCardiovascular DiseaseLeft Ventricular MassDiabetesDiabetes MellitusMedicineAtherosclerosisDiastolic FunctionAnesthesiologyCardiovascular Translational Research